Compare with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES NATCO PHARMA ALKEM LABORATORIES/
NATCO PHARMA
 
P/E (TTM) x 22.9 30.5 74.9% View Chart
P/BV x 5.5 4.3 127.0% View Chart
Dividend Yield % 0.9 0.8 113.1%  

Financials

 ALKEM LABORATORIES   NATCO PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
NATCO PHARMA
Mar-19
ALKEM LABORATORIES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs2,720849 320.4%   
Low Rs1,660557 298.1%   
Sales per share (Unadj.) Rs697.9573.8 121.6%  
Earnings per share (Unadj.) Rs96.1176.0 54.6%  
Cash flow per share (Unadj.) Rs117.3198.2 59.2%  
Dividends per share (Unadj.) Rs25.006.25 400.0%  
Dividend yield (eoy) %1.10.9 128.4%  
Book value per share (Unadj.) Rs515.2842.7 61.1%  
Shares outstanding (eoy) m119.5736.50 327.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.11.2 256.2%   
Avg P/E ratio x22.84.0 570.5%  
P/CF ratio (eoy) x18.73.5 526.6%  
Price / Book Value ratio x4.30.8 509.6%  
Dividend payout %26.03.6 732.4%   
Avg Mkt Cap Rs m261,87925,660 1,020.6%   
No. of employees `00014.35.0 289.1%   
Total wages/salary Rs m15,0553,559 423.0%   
Avg. sales/employee Rs Th5,822.64,225.3 137.8%   
Avg. wages/employee Rs Th1,050.5718.0 146.3%   
Avg. net profit/employee Rs Th802.01,295.9 61.9%   
INCOME DATA
Net Sales Rs m83,44420,945 398.4%  
Other income Rs m1,0421,302 80.0%   
Total revenues Rs m84,48622,247 379.8%   
Gross profit Rs m14,7347,948 185.4%  
Depreciation Rs m2,528810 312.0%   
Interest Rs m651193 337.1%   
Profit before tax Rs m12,5988,247 152.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1051,823 60.6%   
Profit after tax Rs m11,4936,424 178.9%  
Gross profit margin %17.737.9 46.5%  
Effective tax rate %8.822.1 39.7%   
Net profit margin %13.830.7 44.9%  
BALANCE SHEET DATA
Current assets Rs m54,96023,472 234.2%   
Current liabilities Rs m32,4337,287 445.1%   
Net working cap to sales %27.077.3 34.9%  
Current ratio x1.73.2 52.6%  
Inventory Days Days8092 86.3%  
Debtors Days Days7288 81.8%  
Net fixed assets Rs m32,71018,648 175.4%   
Share capital Rs m239365 65.5%   
"Free" reserves Rs m61,36834,525 177.7%   
Net worth Rs m61,60730,760 200.3%   
Long term debt Rs m1,5920-   
Total assets Rs m99,43343,031 231.1%  
Interest coverage x20.443.7 46.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 172.4%   
Return on assets %12.215.4 79.4%  
Return on equity %18.720.9 89.3%  
Return on capital %21.027.4 76.4%  
Exports to sales %19.10-   
Imports to sales %3.00-   
Exports (fob) Rs m15,917NA-   
Imports (cif) Rs m2,483NA-   
Fx inflow Rs m16,06111,536 139.2%   
Fx outflow Rs m2,4832,939 84.5%   
Net fx Rs m13,5788,597 157.9%   
CASH FLOW
From Operations Rs m5,8516,688 87.5%  
From Investments Rs m-7,414-6,122 121.1%  
From Financial Activity Rs m792-509 -155.5%  
Net Cashflow Rs m-73166 -1,107.7%  

Share Holding

Indian Promoters % 66.9 52.0 128.6%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 33.1 7.8 422.2%  
FIIs % 0.0 16.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 26.0 -  
Shareholders   68,381 25,395 269.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  ABBOTT INDIA  DISHMAN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Factors Behind the Sensex Rally, Easy Trip Planners IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended their day on a strong note yesterday. Benchmark indices rallied for the third consecutive day in a row with the BSE Sensex trading above 51,000-mark again

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 3, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - LUPIN COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS